Skip to main content
Open Medicine logoLink to Open Medicine
. 2025 Apr 2;20(1):20259995. doi: 10.1515/med-2025-9995

Retraction of “miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway”

Weidong Zhou 1,, Peifei Li 2, Peihua Jin 3
PMCID: PMC11967482  PMID: 40181836

Retraction of: Zhou W, Li P, Jin P. MiR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway. Open Medicine 2021;16(1):1683–1695, DOI: 10.1515/med-2021-0369

This article has been retracted by agreement between the Editor-in-Chief, Professor Vittorio Calabrese, and the publisher, Walter De Gruyter GMBH, following a thorough investigation. The retraction is due to misleading usage of the figures and undisclosed research outsourcing. Figures 2c, 2d, 2e, and 4b, 4c, 4d were wrongly included in the article and they are not connected to results. In addition, all presented experiments have been conducted by an unspecified external company, which raises questions about the integrity and rigor of the published research.


Articles from Open Medicine are provided here courtesy of De Gruyter

RESOURCES